![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 9/28 | (2006.01) |
(11) | Number of the document | 2914599 |
(13) | Kind of document | T |
(96) | European patent application number | 13796178.5 |
Date of filing the European patent application | 2013-10-29 | |
(97) | Date of publication of the European application | 2015-09-09 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
(46) | Date of publication of the claims translation | 2018-02-12 |
(86) | Number | PCT/US2013/067273 |
Date | 2013-10-29 |
(87) | Number | WO 2014/070745 |
Date | 2014-05-08 |
(30) | Number | Date | Country code |
201261720259 P | 2012-10-30 | US | |
201361791894 P | 2013-03-15 | US |
(72) |
ANDRES, Patricia, US
DATAR, Yogesh, US
GADIRAJU, Ramakrishna, US
KOWALCZYK, Bruce, Andrew, US
KUKLIS, Gabriel, Christian, US
MIRMEHRABI, Mahmoud, CA
PASCHALIDES, Nicholas, US
|
(73) |
Nektar Therapeutics,
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Alfa-6-mPEG6-hidroksikodono, kaip opioidų agonistų, kieta druskos forma ir jos panaudojimas |
SOLID SALT FORM OF ALPHA-6-MPEG6-O-HYDROXYCODONE AS OPIOID AGONISTS AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2019-10-08 | 7 | 162.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2020-10-29 |